Suppr超能文献

非相容 HLA-DPB1 T 细胞表位组错配的方向性不能改善 8/8 匹配的无关供者造血细胞移植中的临床风险分层。

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

机构信息

Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Bone Marrow Transplant. 2017 Sep;52(9):1280-1287. doi: 10.1038/bmt.2017.96. Epub 2017 Jun 5.

Abstract

In 8/8 HLA-matched unrelated donor (UD) hematopoietic cell transplants (HCT), HLA-DPB1 mismatches between alleles from different T-cell epitope (TCE) groups (non-permissive mismatches) are associated with significantly higher risks of mortality compared with those between alleles from the same TCE group (permissive mismatches); however, the relevance of mismatch directionality, that is (host vs graft (uni-directional HvG), graft vs host (uni-directional GvH) or both (bi-directional) in the non-permissive setting is unknown. We show here significantly higher in vitro relative responses (RR) to bi-directional mismatches compared with uni-directional HvG or GvH mismatches in a total of 420 one-way mixed lymphocyte reactions between 10/10 matched pairs (RR 27.5 vs 7.5 vs 15.5, respectively, P<0.001). However, in 3281 8/8 matched UD HCT for leukemia or myelodysplastic syndrome, the hazards of transplant-related mortality (TRM) were similar for uni-directional HvG or GvH mismatches and bi-directional mismatches (hazard ratio (HR) 1.32, P=0.001 vs HR 1.28, P=0.005 and HR 1.34, P=0.046), compared with permissive mismatches. Similar results were observed for overall survival. No statistical differences between the uni- and the bi-directional non-permissive groups were detected in pairwise comparisons for any of the outcomes tested. We conclude that consideration of directionality does not improve risk stratification by non-permissive HLA-DPB1 TCE mismatches in UD searches.

摘要

在 8/8 人类白细胞抗原(HLA)匹配的无关供者(UD)造血细胞移植(HCT)中,来自不同 T 细胞表位(TCE)组的 HLA-DPB1 等位基因之间的错配(非允许性错配)与来自同一 TCE 组的等位基因之间的错配(允许性错配)相比,死亡率显著更高;然而,非允许性错配中错配方向的相关性,即(宿主对移植物(单向 HvG)、移植物对宿主(单向 GvH)或两者(双向)的相关性尚不清楚。我们在此显示,在总共 420 次 10/10 匹配对之间的单向混合淋巴细胞反应中,与单向 HvG 或 GvH 错配相比,双向错配的体外相对反应(RR)显著更高(RR 分别为 27.5、7.5 和 15.5,P<0.001)。然而,在 3281 例白血病或骨髓增生异常综合征的 8/8 匹配 UD HCT 中,与允许性错配相比,单向 HvG 或 GvH 错配和双向错配的移植相关死亡率(TRM)的危险比(HR)相似(HR 分别为 1.32,P=0.001,HR 为 1.28,P=0.005 和 HR 为 1.34,P=0.046)。对于总生存情况也观察到了类似的结果。在任何测试的结果的成对比较中,单向和双向非允许性组之间没有检测到统计学差异。我们得出的结论是,在 UD 搜索中,考虑方向性并不能改善非允许性 HLA-DPB1 TCE 错配的风险分层。

相似文献

4
5
Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
Biol Blood Marrow Transplant. 2014 Nov;20(11):1705-10. doi: 10.1016/j.bbmt.2014.06.026. Epub 2014 Jun 26.
7
HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
Hum Immunol. 2017 Nov;78(11-12):665-671. doi: 10.1016/j.humimm.2017.08.008. Epub 2017 Sep 5.
8
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.
Blood Adv. 2018 Jul 24;2(14):1773-1783. doi: 10.1182/bloodadvances.2018019620.

引用本文的文献

1
Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT.
Blood Adv. 2024 Oct 22;8(20):5438-5449. doi: 10.1182/bloodadvances.2024013677.
3
Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan.
Blood Adv. 2024 Feb 13;8(3):640-652. doi: 10.1182/bloodadvances.2023010598.
4
Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation.
Blood Adv. 2023 Sep 12;7(17):4809-4821. doi: 10.1182/bloodadvances.2022009554.
5
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Haematologica. 2022 Apr 1;107(4):844-856. doi: 10.3324/haematol.2021.278993.
8
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.
Blood. 2019 Sep 19;134(12):924-934. doi: 10.1182/blood.2019001212. Epub 2019 Jul 10.
9
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.
Blood Adv. 2018 Jul 24;2(14):1773-1783. doi: 10.1182/bloodadvances.2018019620.

本文引用的文献

3
Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.
Blood. 2016 Jul 7;128(1):120-9. doi: 10.1182/blood-2015-12-686238. Epub 2016 May 9.
4
Immunogenetics of HLA-DP--A New View of Permissible Mismatches.
N Engl J Med. 2015 Aug 13;373(7):669-72. doi: 10.1056/NEJMe1505539.
5
High HLA-DP Expression and Graft-versus-Host Disease.
N Engl J Med. 2015 Aug 13;373(7):599-609. doi: 10.1056/NEJMoa1500140.
8
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
Blood. 2014 Oct 16;124(16):2596-606. doi: 10.1182/blood-2014-05-576041. Epub 2014 Aug 26.
10
Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.
Transpl Immunol. 2014 Mar;30(2-3):59-64. doi: 10.1016/j.trim.2013.08.006. Epub 2014 Jan 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验